Trial Search Results

An Observational Study of Hepatitis C Virus in Pregnancy

This multi-center observational study examines risk factors for HCV transmission from mother to baby.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

The George Washington University Biostatistics Center

Collaborator: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Stanford Investigator(s):

Eligibility


Inclusion Criteria:

   1. Singleton pregnancy

   2. An HCV antibody positive screen (case) measured using two FDA-approved ELISA tests,
   the Abbott Architect version 3.0 system and the Ortho HCV 3.0.

   3. Gestational age at screening no later than 23 weeks and 6 days, and gestational age at
   enrollment no later than 27 weeks and 6 days, based on clinical information and
   evaluation of the earliest ultrasound as described below.

Exclusion Criteria:

   1. Planned termination of pregnancy

   2. Known major fetal anomalies or demise

   3. Intention of the patient or the managing obstetricians for the delivery to be outside
   a MFMU Network center, unless special provisions are made to insure infant follow-up
   at two and 18 months of age.

   4. Participation in this study in a previous pregnancy.

   5. Unwilling or unable to commit to 18 months of follow-up for HCV positive infants

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Cynthia Willson, RN, BSN
650-724-6372
Recruiting